http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0105486-A3

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-1745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-1785
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-00
filingDate 1983-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1984-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0105486-A3
titleOfInvention 1-monophosphate esters, 1,3-bisphosphate esters and cyclic phosphate esters of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine as antiviral agents
abstract 1-Monophosphate esters, 1,3-bisphosphate esters and ncyclic phosphate esters of 9-(1,3-dihydroxy-2-propoxy­nmethyl)guanine are useful as antiviral agents.
priorityDate 1982-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4199574-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0049072-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0074306-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398740
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226672308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135668175

Total number of triples: 23.